.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Healthtrust
Accenture
UBS
Teva
Farmers Insurance
Daiichi Sankyo
Express Scripts
Mallinckrodt
AstraZeneca

Generated: February 21, 2018

DrugPatentWatch Database Preview

Patents Expiring in April 2031

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer HlthcareKYLEENAlevonorgestrelINTRAUTERINE DEVICE;INTRAUTERINE208224-001Sep 16, 2016RXYesYes➤ Sign Up➤ Sign UpY
Bayer HlthcareSKYLAlevonorgestrelINTRAUTERINE DEVICE;INTRAUTERINE203159-001Jan 9, 2013RXYesYes➤ Sign Up➤ Sign UpY
Bayer HlthcareMIRENAlevonorgestrelINTRAUTERINE DEVICE;INTRAUTERINE021225-001Dec 6, 2000RXYesYes➤ Sign Up➤ Sign UpY
Bayer HlthcareSTIVARGAregorafenibTABLET;ORAL203085-001Sep 27, 2012RXYesYes➤ Sign Up➤ Sign UpY
Abbvie IncTECHNIVIEombitasvir; paritaprevir; ritonavirTABLET;ORAL207931-001Jul 24, 2015RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF HCV INFECTION USING PARITAPREVIR
Abbvie IncVIEKIRA PAK (COPACKAGED)dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirTABLET, TABLET;ORAL206619-001Dec 19, 2014RXYesYes➤ Sign Up➤ Sign UpYY
Abbvie IncVIEKIRA PAK (COPACKAGED)dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirTABLET, TABLET;ORAL206619-001Dec 19, 2014RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF HCV INFECTION USING PARITAPREVIR
Abbvie IncVIEKIRA XRdasabuvir sodium; ombitasvir; paritaprevir; ritonavirTABLET, EXTENDED RELEASE;ORAL208624-001Jul 22, 2016RXYesYes➤ Sign Up➤ Sign UpYY
Abbvie IncVIEKIRA XRdasabuvir sodium; ombitasvir; paritaprevir; ritonavirTABLET, EXTENDED RELEASE;ORAL208624-001Jul 22, 2016RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF HCV INFECTION USING PARITAPREVIR
Boehringer IngelheimSPIRIVA RESPIMATtiotropium bromideSPRAY, METERED;INHALATION021936-001Sep 24, 2014RXYesYes➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
McKinsey
US Army
Covington
Medtronic
Novartis
Fuji
AstraZeneca
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot